tiprankstipranks
Trending News
More News >
Interpace Diagnostics Group Inc. (IDXG)
:IDXG
US Market

Interpace Diagnostics Group (IDXG) Income Statement

Compare
413 Followers

Interpace Diagnostics Group Income Statement

Last quarter (Q3 2025), Interpace Diagnostics Group's total revenue was $8.76M, a decrease of -28.91% from the same quarter last year. In Q3, Interpace Diagnostics Group's net income was $911.00K. See Interpace Diagnostics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 46.93M$ 40.21M$ 31.84M$ 41.31M$ 32.40M
Gross Profit
$ 29.93M$ 23.90M$ 18.23M$ 17.95M$ 10.72M
Operating Expenses
$ 21.82M$ 21.10M$ 22.07M$ 29.68M$ 37.28M
Depreciation and Amortization
$ 748.00K$ 1.03M$ 2.56M$ 5.37M$ 5.50M
EBITDA
$ 8.36M$ 3.84M$ -2.27M$ -1.33M$ -20.10M
Operating Income
$ 8.11M$ 2.80M$ -3.84M$ -11.74M$ -26.55M
Other Income/Expenses
$ -1.16M$ -1.68M$ -2.22M$ -1.41M$ -82.00K
Pretax Income
$ 6.95M$ 1.13M$ -5.84M$ -15.41M$ -26.15M
Net Income
$ 6.70M$ 802.00K$ -5.87M$ -14.75M$ -26.20M
Per Share Metrics
Basic EPS
$ 1.42$ 0.19$ -1.38$ -3.57$ -6.50
Diluted EPS
$ 0.40$ 0.18$ -1.38$ -3.57$ -6.50
Weighted Average Shares Outstanding
4.39M 4.32M 4.24M 4.13M 4.03M
Weighted Average Shares Outstanding (Diluted)
4.39M 4.36M 4.24M 4.13M 4.03M
Currency in USD

Interpace Diagnostics Group Earnings and Revenue History